Human gene therapy. First experiment approved.

Human gene therapy. First European experiment.

Obinutuzumab approved for CLL: Monoclonal antibody product is first FDA-approved breakthrough therapy.

[First biosimilar infliximab approved].

The first adeno-associated virus gene transfer experiment, 1983.

First recombinant Factor XIII approved.

Predictive biomarkers for checkpoints, first tests approved.

First UK trial of AIDS vaccine approved.

First vanguard anti-MRSA agent approved.

First biosimilar drug approved in the USA.

Obinutuzumab for chronic lymphocytic leukemia: promise of the first treatment approved with breakthrough therapy designation.

Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.

Revlimid (Lenalidomide) Now FDA Approved as First-Line Therapy for Patients with Multiple Myeloma.

Repurposing clinically approved cephalosporins for tuberculosis therapy.

Permanent cardiac pacing: first Congolese experiment.

Live attenuated vaccine: the first clinically approved dengue vaccine?

Zarxio (Filgrastim-sndz): First Biosimilar Approved in the United States.

Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment.

Zarxio (Filgrastim-sndz): The First Biosimilar Approved by the FDA.

First QIDP drug approved, but designation may fail urgent needs.

First International Workshop on Human Gene Transfer.

First biosimilar drug approved for sale in the United States.

Human gene therapy and congress.

FDA-approved medications that impair human spermatogenesis.

Empliciti (Elotuzumab): First SLAMF7 Antibody Therapy Approved for the Treatment of Patients with Previously Treated Multiple Myeloma.

Suggest Documents

Human gene therapy. First European experiment.

Obinutuzumab approved for CLL: Monoclonal antibody product is first FDA-approved breakthrough therapy.

[First biosimilar infliximab approved].

The first adeno-associated virus gene transfer experiment, 1983.

First recombinant Factor XIII approved.

Predictive biomarkers for checkpoints, first tests approved.

First UK trial of AIDS vaccine approved.

First vanguard anti-MRSA agent approved.

First biosimilar drug approved in the USA.

Obinutuzumab for chronic lymphocytic leukemia: promise of the first treatment approved with breakthrough therapy designation.

Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.

Revlimid (Lenalidomide) Now FDA Approved as First-Line Therapy for Patients with Multiple Myeloma.

Repurposing clinically approved cephalosporins for tuberculosis therapy.

Permanent cardiac pacing: first Congolese experiment.

Live attenuated vaccine: the first clinically approved dengue vaccine?

Zarxio (Filgrastim-sndz): First Biosimilar Approved in the United States.

Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment.

Zarxio (Filgrastim-sndz): The First Biosimilar Approved by the FDA.

First QIDP drug approved, but designation may fail urgent needs.

First International Workshop on Human Gene Transfer.

First biosimilar drug approved for sale in the United States.

Human gene therapy and congress.

FDA-approved medications that impair human spermatogenesis.

Empliciti (Elotuzumab): First SLAMF7 Antibody Therapy Approved for the Treatment of Patients with Previously Treated Multiple Myeloma.

Human gene therapy. First experiment approved.

Recommend Documents

Follow Us